Primary Hyperoxaluria Type 1: The First Patient Treated with Lumasiran in Portugal
Primary hyperoxaluria type 1 is a rare genetic disease caused by mutations in AGXT, leading to an excessive hepatic production of oxalate, resulting in urolithiasis, nephrocalcinosis and chronic kidney disease. The authors present the case of a young female with PH1 who is the first patient treate...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Publicações Ciência e Vida
2023-06-01
|
Series: | Revista Portuguesa de Nefrologia e Hipertensão |
Subjects: | |
Online Access: | https://spnefro.pt/_doi/1a04465e-62e7-4027-a6ec-4aa67429960e/b59869c2-7aae-4a8e-bc24-b95ec315086c |